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The genomic duplication associated with Potocki-Lupski syndrome (PTLS) maps in close proximity to the duplication associated with
Charcot-Marie-Tooth disease type 1A (CMT1A). PTLS is characterized by hypotonia, failure to thrive, reduced body weight, intellectual
disability, and autistic features. CMT1A is a common autosomal dominant distal symmetric peripheral polyneuropathy. The key dosage-
sensitive genes RAI1 and PMP22 are respectively associatedwith PTLS and CMT1A. Recurrent duplications accounting for themajority of
subjects with these conditions are mediated by nonallelic homologous recombination between distinct low-copy repeat (LCR) sub-
strates. The LCRs flanking a contiguous genomic interval encompassing both RAI1 and PMP22 do not share extensive homology;
thus, duplications encompassing both loci are rare and potentially generated by a different mutational mechanism. We characterized
genomic rearrangements that simultaneously duplicate PMP22 and RAI1, including nine potential complex genomic rearrangements,
in 23 subjects by high-resolution array comparative genomic hybridization and breakpoint junction sequencing. Insertions and micro-
homologies were found at the breakpoint junctions, suggesting potential replicative mechanisms for rearrangement formation. At the
breakpoint junctions of these nonrecurrent rearrangements, enrichment of repetitive DNA sequences was observed, indicating that they
might predispose to genomic instability and rearrangement. Clinical evaluation revealed blended PTLS and CMT1A phenotypes with a
potential earlier onset of neuropathy. Moreover, additional clinical findings might be observed due to the extra duplicated material
included in the rearrangements. Our genomic analysis suggests replicative mechanisms as a predominant mechanism underlying
PMP22-RAI1 contiguous gene duplications and provides further evidence supporting the role of complex genomic architecture in
genomic instability.Introduction
Contiguous gene syndromes are caused by chromosome
abnormalities that affect multiple contiguous genes and
change the gene organization and/or dosage on a chromo-
some. Such syndromes are mostly rare, sporadic, and
heterogeneous with a wide spectrum of clinical pheno-
types.1 Contiguous gene syndromes, in contrast to genetic
disorders caused by point mutations, result from the rear-
rangements of large genomic intervals.2,3 Conditions re-
sulting from such changes are referred to as genomic disor-
ders.4 The rearrangements might disrupt the structural
integrity of a gene or alter the copy number of dosage-sen-
sitive genes by generating copy-number variants (CNVs),
which are submicroscopic, unbalanced structural variants
ranging from kilobases (kb) to megabases (Mb) in size.5
These CNV result in locus specific deviation from the
normal diploid state.2
Copy-number gain or loss of a specific genomic interval
might result in genomic disorders with distinct pheno-
types. For example, duplication of chromosome 17p11.2
results in Potocki-Lupski syndrome (PTLS [MIM 610883]),
while its reciprocal deletion leads to Smith-Magenis syn-1Department of Molecular and Human Genetics, Baylor College of Medicin
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The Americandrome (SMS [MIM 182290]).6-8 Phenotypes resulting
from reciprocal CNVs in dosage-sensitive genes can convey
mirror image traits as shown for weight/body mass in sub-
jects with PTLS (lean) and SMS (obese), and the corre-
sponding chromosome-engineered mouse models.9,10
Mechanistically, from a structural variant mutagenesis
viewpoint, nonallelic homologous recombination (NAHR)
has been demonstrated as themajormolecular mechanism
for disease-causing recurrent genomic rearrangements.5
NAHR utilizes long homologous repeats, such as low-copy
repeats (LCR), as substrates to mediate structural changes
of chromosomes. Twomajor LCRclusters flank the SMScrit-
ical region onhuman chromosome 17p11.2 in direct orien-
tation, termed proximal and distal SMS-REPs.11 Unequal
crossover between the proximal anddistal SMS-REPs results
in the ~3.6Mbcommon recurrent SMSdeletion observed in
~70%–80% of SMS cases, as well as the reciprocal ~3.6 Mb
common recurrent PTLS duplication observed in ~60%–
70% of PTLS cases.7,12-15 Besides these NAHR-mediated
recurrentCNVs, duplicationswith a broad size distribution,
i.e., nonrecurrent, have been identified in subjects with
PTLSphenotypes. These duplications are unique to individ-
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NAHR.16 The smallest region of overlap (SRO) analysis of
these duplications narrowed the critical region of PTLS to
a 125 kb interval solely encompassing RAI1 (retinoic acid
induced 1 [MIM 607642]), a dosage sensitive gene respon-
sible for SMS and likely for PTLS.16-19
The 17p12 locus, distal to the SMS/PTLS critical region,
presents with two other LCR clusters (termed CMT1A-
REPs) that can also be substrates for NAHR. NAHR between
the two CMT1A REPs results in the common recurrent
~1.4 Mb duplication associated with Charcot-Marie-Tooth
disease type 1A (CMT1A [MIM 118220]).20-22 The dosage-
sensitive gene PMP22 (peripheral myelin protein 22
[MIM 601097]) is included in the CMT1A duplication,
and has been shown to be responsible for CMT1A.23 Anal-
ogous to the distinct clinical SMS/PTLS phenotypes associ-
ated with reciprocal 17p11.2 rearrangements, a reciprocal
deletion of CMT1A duplication results in hereditary neu-
ropathy with liability to pressure palsies (HNPP [MIM
162500]), a condition distinct from CMT1A.24
Common recurrent PTLS duplication and CMT1A dupli-
cation are independent genomic rearrangement events,
because they utilize distinct LCR pairs. RAI1 and PMP22,
associated with PTLS and CMT1A, respectively, are in close
physical proximity in the human genome—the distance
between them is approximately 2.5 Mb. As a result, dupli-
cations encompassing both genes are observed.6,14,23,25-29
We termed such duplications PMP22-RAI1 contiguous
gene duplications, or in short, PMP22-RAI1 duplications.
However, a systematic analysis and documentation of
these duplications with a focus on molecular mechanisms
and detailed phenotyping is lacking. In contrast to inde-
pendent recurrent PTLS and CMT1A duplications deter-
mined by LCR substrates, the PMP22-RAI1 duplications
are nonrecurrent and not delimited by highly identical
LCRs; thus they potentially arise from mechanisms other
than NAHR. Replicative mechanisms, such as fork stalling
and template switching/microhomology-mediated break-
induced replication (FoSTeS/MMBIR), have been proposed
to generate nonrecurrent rearrangements independent of
LCRs.25,26 These replication-based mechanisms, as
opposed to NAHR, might contribute to the formation of
the PMP22-RAI1 duplications. Furthermore, we investi-
gated whether copy-number gains of two distinct dosage-
sensitive genes led to a new contiguous gene syndrome
that appeared clinically to represent more than the addi-
tion of the two resultant genomic disorders.1
The clinical presentation of PTLS includes infantile hy-
potonia, failure to thrive, intellectual disability, autistic
features, sleep apnea, and structural cardiovascular anom-
alies.7,14,27 Phenotypic variability has been observed in
subjects harboring different duplication sizes, all of which
encompass RAI1.7,16 CMT1A is the most common in-
herited peripheral neuropathy in humans and is character-
ized by distal symmetric polyneuropathy, distal muscle
atrophy, foot deformities and a steppage gait, reduced
deep tendon reflexes, decreased nerve conduction veloc-
ities, and hypertrophic neuropathy on nerve biopsy.22692 The American Journal of Human Genetics 97, 691–707, NovembWe hypothesize that duplications encompassing both
RAI1 and PMP22 might possibly confer a blended pheno-
type with potential additive clinical presentations, which
might result from the interplay between the phenotypes
of infantile hypotonia characteristic of PTLS and periph-
eral neuropathy, the hallmark of CMT1A.7,28,29 This model
is consistent with a hypothesis of ‘‘mutational load’’ due to
a CNVencompassing two dosage-sensitive genes. It also re-
flects the feature of a wide spectrum of clinical phenotypes
in contiguous gene syndromes, which might be associated
with the number of genes involved.1,30
In the current study, we report 23 subjects identified
with nonrecurrent PMP22-RAI1 duplications with sizes
ranging from 3.2 Mb to 19.7 Mb. High-resolution array
comparative genomic hybridization (array CGH) followed
by breakpoint junction sequencing allowed for precise
demarcation of the boundaries of the duplications, and re-
vealed mutational signatures that enable us to surmise
the potential molecular mechanisms for generating the
observed genomic rearrangements. We explore the possi-
bility that perturbation of two well-characterized dosage-
sensitive genes might result in a phenotype that is
exacerbated in comparison to the individual contribution
of each gene. PTLS often presents in infancy, but CMT1A
usually presents later in the first or even second decade
of life. Thus, the molecular diagnosis in the subjects with
PMP22-RAI1 contiguous gene duplication syndrome often
precedes the clinical onset of neuropathy and can help
facilitate timely intervention and clinical management.
Moreover, the concurrence of PTLS and CMT1A suggests
an early molecular diagnosis for subjects with PTLS in
order to periodically assess for potential neuropathy. In
summary, our study, focusing on both genotype-pheno-
type correlation and the underlying molecular mecha-
nism, provides a systematic investigation of a group of
subjects with genomic rearrangements that can lead to
overlapping phenotypic outcomes blending clinical as-
pects of both PTLS and CMT1A.Experimental Procedures
Human Subjects
A total number of 127 subjects with proximal chromosome 17p
duplication encompassing RAI1 were enrolled in a research proto-
col approved by the Institutional Review Board for Baylor College
of Medicine and Affiliated Hospitals. Informed consent was ob-
tained from the subjects and parents or legal guardians of the sub-
jects. Genomic DNA was extracted from whole blood using the
Gentra Puregene Blood Extraction Kit per manufacturer’s protocol
(QIAGEN). All genomic studies, including array CGH and break-
point junction sequencing (below), were performed on DNA sam-
ples extracted from whole blood.
Twenty-three out of 127 subjects were identified with the
PMP22-RAI1 duplication. Molecular data were available for all sub-
jects, while clinical information was available for 17 of the 23 sub-
jects (Table 1 and Table S1). BABs 527,31 1458,32 1861,29 2211,7
2337,33 2362,7 2488,7 and 266128 were reported with both clinicaler 5, 2015
and molecular studies. We revisited their clinical data combining
the medical charts and published clinical information. BABs
1229,7 2703,16 2711,25 and 279016 were reported previously
without clinical information included in the report. Medical re-
cords of these subjects were carefully evaluated. BABs 3813,
6299, 6504, 6635, 6636, 6966, 6967, 6968, 7679, 7873, and
8300 were recently enrolled subjects without any clinical or cyto-
genetic information reported.17p Array CGH
We designed a 4 3 180K format array CGH (AMADID# 032121,
Agilent Technologies) with high-density probes tiling the critical
region of CMT1A and PTLS in chromosome region 17p11.2p12.
The probe density averaged 10 oligonucleotides per kb for
17p11.2p13.1, one oligonucleotide per kb for 17p13.2p13.3, one
oligonucleotide per 2 kb for the remainder of chromosome 17,
and one oligonucleotide per 100 kb for the rest of the genome. Re-
petitive sequences and repeats (e.g., LCRs) were not densely inter-
rogated by this design.
We also designed an 8 3 60K format array CGH (AMADID#
070922, Agilent Technologies) tiling the LCR-rich intervals in
chromosome regions 17p11.2p12 with an average probe density
of 10 oligonucleotides per kb in order to interrogate breakpoint
boundaries inside LCRs.
The experimental procedures, including DNA fragmentation
and labeling, array hybridization, washing, scanning, and image
processing were performed according to the manufacturer’s proto-
col (Agilent Oligonucleotide Array-Based CGH for Genomic DNA
Analysis, Version 7.2, Agilent Technologies) with modifications.
1.2 mg genomic DNA from proband and control (NA15510) were
digested with AluI and RsaI (Promega) at 37C for 2 hr. A 1%
agarose gel was run to verify the digestion product. Labeling of
the digestion product was performed using BioPrime Array CGH
Genomic Labeling Module (Life Technologies) following the man-
ufacturer’s protocol. Cy5-dCTP and Cy3-dCTP from Cyanine
Smart Pack dCTP (PerkinElmer) were used for labeling proband
and control digestion product, respectively, at 37C for 2 hr. Ami-
con Ultra 0.5 Centrifugal Filter (30 kDa, Millipore) was used to pu-
rify labeling product. Labeling efficiency was quantitated using
NanoDrop ND-1000 UV-VIS spectrophotometer. Labeled proband
and control samples were combined in a mass ratio of 1:1 with
addition of 5 mg human Cot-1 DNA (Life Technologies), 10X
Agilent Blocking Agent (Agilent Technologies), and 2X Hi-RPM
Hybridization Buffer (Agilent Technologies). The mixture was
incubated at 95C for 3 min and then at 37C for 30 min for
pre-hybridization, after which the mixture was placed onto the
array and into a hybridization chamber (Agilent Technologies)
in a rotating oven (Agilent Technologies) for at least 40 hr at
65C.Washing steps after hybridization were performed following
the manufacturer’s protocol with Agilent Oligo CGH Wash Buffer
1 and 2 (Agilent Technologies), acetonitrile (Sigma-Aldrich), and
Stabilization and Drying Solution (Agilent Technologies). The
dried slides were scanned on Agilent Microarray Scanner with
SureScan High-Resolution Technology (model G2565CA, Agilent
Technologies) for image acquisition. The scanned images were
subsequently processed by Feature Extraction Software version
11.5 (Agilent Technologies) to generate FE files, which were subse-
quently imported into Agilent Genomic Workbench version 7.0
(Agilent Technologies) for CNV analysis. Copy number was
defined by normalized log2 ratio of Cy5/Cy3 fluorescence signal
of each probe. The human genome reference sequence GRCh37/The Americanhg19 was used to define the genomic coordinates of detected
CNVs. Array CGH experiments were performed on DNA samples
from trios to identify de novo CNVs.
Breakpoint Junction Sequencing
High-resolution array CGH revealed copy-number transitions.
Long-range PCR was performed to amplify the breakpoint junc-
tions. Forward and reverse primers were designed using the se-
quences from the estimated boundaries of the rearrangements
defined by array CGH. TaKaRa LA Taq (Clontech) was used for
the PCR amplifications. The thermocycler was programmed at:
98C 3 30 s; 35 cycles of 95C 3 60 s, 65C 3 20 s, 68C 3
20 min; 68C 3 10 min. Sanger sequencing was performed for
the PCR products, and the DNA sequences were compared to the
reference genome (hg19) using BLAT in order to map the break-
point junctions.
LCR Density Analysis
A list of LCRs annotated with genomic coordinates was down-
loaded from the Segmental Dups track in UCSC Genome Browser
(GRCh37/hg19). LCR density is estimated by calculating the ratio
of the sum of different subsets of genomic intervals annotated
with LCR sequences over the entire genomic interval investigated.
An interval will be countedmultiple times if it is withmultiple LCR
annotations. Thus the densitymight be higher than 1. Themoving
average is plotted by creating a 100 kb sliding window containing
the interval to be investigated and sliding each time by 50 kb.Results
Clinical Profiling of Contiguous Gene PMP22-RAI1
Duplication Syndrome
To date, we have enrolled 127 subjects with proximal chro-
mosome 17p duplication encompassing RAI1 in research
protocols, and 84/127 (66%) subjects were identified
with the common recurrent PTLS duplication. Of the re-
maining 43 subjects, 23 (53%) were found to have contig-
uous gene duplications encompassing both PMP22 and
RAI1. Clinical records of 17/23 subjects with such duplica-
tions were available for review (Table 1). The clinical
and/or molecular findings of 10 of these subjects were
included in previous publications (Table 1). Three of the
subjects had additional cytogenetic abnormalities on other
chromosomes, including a 47,XYY male (Table S1). The
most consistently reported clinical features were feeding
difficulties, global developmental delay, behavioral diffi-
culties, and language delay. Age at walking ranged from
15months to 6 years. Nine subjects presented with clinical
neuropathy by 10 years of age; six of these were younger
than 5 years (BABs 527, 1229, 2211, 2362, 2661, 3813).
Data regarding the presence or absence of clinical neurop-
athy is not available on 4 of the 17 subjects (Table 1). Four
subjects had renal involvement, including three subjects
with structural renal abnormalities and one previously
published subject with Alport syndrome.32 Congenital
heart malformations were present in eight subjects, with
five of these involving the left ventricular outflow system.
Two subjects had syringomyelia. In BAB 2211, theJournal of Human Genetics 97, 691–707, November 5, 2015 693
Table 1. Clinical Information of the Subjects with PMP22-RAI1 Contiguous Gene Duplications
Identifier 527 1229 1458 1861 2211 2337 2362 2488
Ref 30 7 31 28 7 32 7 7
Sex M M M F M M M M
Age at last exam 9 y 4.5 y 19 m 7.5 y 4 y 10 m 11 m 11 y 6 m 9 y
Infancy Feeding
difficulties
þ NR NR þ þ NR þ þ
Failure to thrive þ þ þ  þ þ  þ
Infantile
hypotonia
þ   þ þ þ þ þ
Development Developmental
delay
þ þ þ þ þ þ þ þ
Age at walking 6 y 24 m NR 4.5 y 18 m NR 24 m 15 m
Behavioral
difficulties
þ þ NR NR þ NR þ þ
Language delay þ þ NR þ þ NR þ þ
Clinical
neuropathy
(age at onset),
exercise
intolerance
þ (infancy) þ NR þ þ NR þ (22 m) þ
Sleep
disturbance
þ  NR NR þ NR þ NR
Physical
features
Facial
dysmorphism a
þ þ þ þ þ NR þ þ
Foot
deformities
Sandle gap,
2-3 syndactyly
 NR Congenital talipes
equinovarus
hyperpronation
of feet
bilateral
talipes
equinovarus
bilateral
pes
planus,
hindfoot
valgus
þ
Unusual gait/
dropped foot
þ þ NR þ þ NR Wide-
based
gait

Distal extremity
weakness or
atrophy
Hypertonicity
lower
extremities
þ NR þ þ NR þ þ
Sensory loss þ  NR NR þ NR þ 
Reduced or absent
ankle DTRs
þ þ NR þ þ NR þ þ
Studies and
imaging
Brain MRI
abnormality
þ  NR þ þ NR  NR
Syringomyelia  NR NR NR þ NR NR NR
Congenital
heart defect
DORV, VSD,
ASD,
overriding
aorta
NR NR NR Dilated aortic
root, aortic
aneurysm,
bicuspid aortic
valve, PFO,
possible VSD
Bicuspid
aortic valve
NR NR
Renal
abnormality
Small cysts NR Alport
syndrome
 Malrotation left
kidney
NR  NR
Median nerve
motor NCV
(m/sec)
20.1 19.7 NR NR 15.4 (peroneal) NR 23.2 NR
Median nerve
distal CMAP (mV)
6 3.4 NR NR 2.4 NR 6.8 NR
Abbreviations are as follows: ASD, atrial septal defect; CMAP, compound muscle action potential; DORV, double outlet right ventricle; LSVC, left superior vena
cava; NCV, nerve conduction velocity; NR, not reported; PFO, patent foramen ovale ; VSD, ventricular septal defect; y, years; m, months.
aDetails are included in Table S1.
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2661 2711 3813 6504 6635 6636 7679 7873 8300
27 24       
F F M M M M M M F
2 y 9 m 3 y 3 y 3.5 y 33y 13 y 15 m 22 m 3 y 11 m
þ þ NR þ þ þ þ þ 
þ   þ þ þ  þ 
þ þ þ þ þ þ þ þ þ
þ þ þ þ þ þ þ þ þ
28 m 19 m 24 m NR 24 m 4 y Not yet at 15 m Not yet at 22 m 19 m
þ þ þ NR þ þ NR  
þ þ þ þ þ þ þ þ þ
þ (Before
2 y)
 þ NR 15y þ (first decade)   NR
NR þ  NR NR þ NR  þ
þ þ þ NR þ þ þ þ þ
NR   þ bilateral pes planus,
hindfoot valgus
bilateral pes
cavus, unilateral
equinovarus
 bilateral pes planus,
hindfoot valgus
hindfoot
valgus
Ataxic gait þ þ NR þ Wide-based gait   þ
NR  þ Generalized hypotonia;
increased tone on left
arm and leg
þ þ þ hypotonia without
muscular weakness
þ
NR  NR NR  þ NR NR NR
þ  þ NR þ þ þ  þ
 þ NR þ NR þ þ  
þ NR NR NR NR  NR NR NR
VSD    Dilated aortic root  ASD/PFO,
persistent LSVC
Dysplastic aortic
valve
Dilated aortic
root
NR  NR NR   hydronephrosis  
decreased NR NR NR NR 24 NR NR NR
NR NR NR NR NR NR NR NR NR
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Figure 1. Genomic Rearrangements Encompassing PMP22-RAI1 Duplications in 23 Subjects
The genomic rearrangements are shown by array CGH log2 ratio plots. The plot focuses on the short arm of chromosome 17 and a short
extension into the long arm, separated by a gap representing the centromeric region. The rearrangement patterns characterized by array
CGH are noted underneath each array CGH log2 ratio plot. BABs 1861, 2362, 2488, 2661, 2703, 3813, 6299, 6635, 6636, 6966, 6968,
7679, 7873, and 8300 (14/23, 60.87%) are observed to have simple duplications (DUP). BABs 1229, 2711, and 6967 (3/23, 13.04%)
are found to have a distal deletion sequentially followed by a normal copy segment and a proximal duplication (DEL-NML-DUP pattern).
BABs 527, 2211, 2790, and 6504 (4/23, 17.39%) are shown to have a distal duplication sequentially followed by a normal copy segment
and a proximal duplication (DUP-NML-DUP pattern). Breakpoint sequencing of BAB 2790 further reveals that the distal side of the distal
DUP joins the distal side of the proximal DUP in an inverted orientation, representing a DUP-NML-INV/DUP pattern. BAB 1458 (1/23,
4.35%) is found to have a triplication sequentially followed by a normal copy segment and a proximal duplication (TRP-NML-DUP
pattern). BAB 2337 (1/23, 4.35%) had a highly complex rearrangement pattern of, from distal to proximal 17p and connected by normal
copy segments, a terminal deletion (DEL1), a small duplication (DUP1), a deletion (DEL2) and a large duplication encompassing PMP22
and RAI1 (DUP2) with two small triplicated segments (TRP1 and TRP2) residing within it (DEL1-NML-DUP1-NML-DEL2-NML-DUP2-
TRP1-DUP2-TRP2-DUP2 pattern). The plots are arranged according to the starting coordinate of the rearrangements identified in
each case. Abbreviations are as follows: DUP, duplication; DEL, deletion; TRP, triplication; NML, normal copy segment. Red (log2 ratio
> 0.25), black (0.25% log2 ratio% 0.25) and green (log2 ratio < 0.25) dots represent array CGH probes. Red/green horizontal lines
mark theoretical log2 ratio of duplication (0.58) / heterozygous deletion (1.0). Black arrows denote small CNVs. Black vertical lines
mark positions of PMP22 and RAI1.syringomyelia extended from T5 to T12 and was associated
with a tethered cord, whereas in BAB 2661 it was a cervical
syringomyelia (C4–C7) with an otherwise normal brain
and spine MRI.
Nonrecurrent PMP22-RAI1 Duplications
Duplications encompassing both PMP22 and RAI1 were
identified in 23 sporadic subjects. Using array CGH target-
ing chromosome 17p, we obtained a high-resolution
delineation of the size, extent, and gene content of these
duplications (Figure 1). 14/23 cases (60.87%) had appar-
ently simple duplication rearrangements (Figure 1, Table 2).
No additional CNVs other than the PMP22-RAI1 duplica-
tions were observed on chromosome 17p in these cases.
Interestingly, potential complex genomic rearrangements
(CGRs) with higher-level structural complexities were696 The American Journal of Human Genetics 97, 691–707, Novembobserved in 9/23 cases (39.13%). The CGR pattern in such
cases included duplications (DUP), deletions (DEL), and
triplications (TRP), often intervened by segments with a
normal (NML) copy number (refer to Figure 1 and Table 2
for details). Thus, the PMP22-RAI1 duplications are either
simple duplications or involved in CGRs with the SRO en-
compassing both PMP22 and RAI1 in their entirety. They
have variable genomic sizes (from 3.2 Mb in BAB 3813 to
19.7 Mb in BAB 6968) and boundaries of duplicated seg-
ments, documenting nonrecurrent duplications.
We performed array CGH analysis on 14 trios (subjects
and their unaffected parents) to investigate the inheritance
pattern of the rearrangements observed in the subjects.
The results suggested that the rearrangements arose
de novo in all the 14 subjects (Table 2). Among these,
7/14 (50%) were potential de novo CGRs with higher-leveler 5, 2015
structural complexity (Table 2). Trio analysis was not per-
formed for the remaining nine families, as no or only
one parental sample was available for each affected subject.
Thus the inheritance pattern of the rearrangements identi-
fied in the subject was not available (Table 2).
Replicative Mutational Mechanism Underlying
PMP22-RAI1 Duplications
Weattempted long-range PCR for thebreakpoint junctions,
boundaries of which were estimated by high-resolution
arrayCGH. Sanger sequencingwas performed for the break-
point junctions that achieved successful PCRamplification.
Potential molecular mechanisms underlying the genomic
rearrangements could be surmised from the ‘‘mutational
signatures’’ uncovered at the breakpoint junctions.
Among the 23 nonrecurrent rearrangements identified
in 23 subjects, 14 were characterized as simple duplications
by array CGH. In these subjects, we expect 14 putative
breakpoint junctions, five of which were successfully
amplified and sequence determined (Figure S1). Microho-
mologies were identified in BABs 2661 (AT),25 6636 (A),
6966 (TCAG), and 8300 (CCT) at the breakpoint junction,
which are consistent with a potential FoSTeS/MMBIR
mechanism.25,26,34 Other mechanisms, including micro-
homology-mediated end-joining (MMEJ),35 might provide
alternative explanations for the mechanism underlying
these simple duplications observed on 17p. The microho-
mology-mediated template-switch event might occur
once, at this resolution level, for generating each of the
observed duplications in BABs 2661, 6636, 6966, and
8300 (Figure S1A). In contrast, in the fifth sample BAB
3813, a 17 bp inserted sequence (GCTGTGATTCTG
TAAGC) was identified at the breakpoint junction. This in-
serted genomic segment could be partially derived from a
nearby region (Chr17: 15060672–15060686, Figure S1B).
This breakpoint junction feature might be explained by
FoSTeS/MMBIR via iterative template switches copying
genomic sequences from multiple nearby regions of the
breakpoint junction (Figure S1B).
Breakpoint junction sequences were not obtained in the
remaining nine cases, because they map at the pericentro-
meric or centromeric regions within extensive repeats and
repetitive sequences, such as LCR or satellite DNA se-
quences (Figure 2). These sequences limit the experimental
approaches to sequencing breakpoint junctions not
involving long stretch of homologous sequences. Array
CGH targeting LCR sequences on 17p were designed to
narrow down those breakpoint junctions within LCRs.
However, it was not always successful due to the limited
dynamic range and capability of array CGH to reveal tran-
sitions between higher order copy number (e.g. quadrupli-
cation versus triplication).
PMP22-RAI1Duplications Can Be Part of CGRs on 17p
Several PMP22-RAI1 duplications were identified previ-
ously using conventional cytogenetic diagnostic methods,
such as fluorescence in situ hybridization (FISH) orThe Americanchromosome G-banding analyses.28,29,32 However, these
methods are not able to detect submicroscopic structural
complexities. High-resolution array CGH can reveal more
extensive structural complexities with high-density probes
interrogating the region of interest. We utilized high-reso-
lution 17p array CGH and found evidence for other CNVs
in addition to the PMP22-RAI1 duplications, constituting
potential CGRs.
Three cases were identified with a CGR pattern of ‘‘DEL-
NML-DUP’’ (Figure 1). The CGR in BABs 1229 and 2711
were not identified in either parent, and likely arose de
novo in the subject (Table 2). Breakpoint junction
sequencing revealed 1 bp insertion (C) and 6 bp (ACCTTC)
microhomology at the deletion breakpoint in BABs 2711
and 1229 respectively.25 The duplication breakpoints
were not sequenced as they map in pericentromic and
centromeric regions (Figure 2). The inheritance pattern of
the rearrangement observed in BAB 6967 is unknown as
the parental samples were not available.
Four cases were identified with a CGR pattern of ‘‘DUP-
NML-DUP’’ (Figure 1). The CGR in BABs 527, 2211, and
6504 were de novo according to the array CGH analysis
in trio studies (Table 2). The partially mapped breakpoint
junction sequence in BAB 2211 revealed that the proximal
side of the distal DUP was connected to the distal side of
the proximal DUP in a direct orientation (Figure S2A). A
6 bp inserted palindrome sequence (TAATTA) was observed
at the breakpoint. The inheritance pattern of the CGR in
BAB 2790 was unknown as parental samples were unavai-
lable. Breakpoint junction sequencing revealed that the
distal side of the distal DUP was connected to the distal
side of the proximal DUP in an inverted orientation
(INV/DUP), consistent with a potential DUP-NML-INV/
DUP rearrangement (Figure S2B). A 4 bp inserted sequence
(CTTT) at the breakpoint was identified previously, which
possibly originated from a nearby sequence (Chr17:
12999823–12999830), with two 2 bp microhomologies
(TT and CA) flanking the 4 bp insertion (Figure S2B).16
The mutational signatures identified in the CGRs of BABs
2211 (insertion) and 2790 (insertion and microhomology)
are indicative of potential replication-based mechanisms
such as FoSTeS/MMBIR.
De novo CGR with a pattern of ‘‘TRP-NML-DUP’’ was
identified by high-resolution array CGH in BAB 1458
(Table 2). Breakpoint junction sequencing was attempted
but not successfully obtained. The lack of amplification
might be due to additional structural complexities not
resolved by array CGH (such as inversions) in addition to
the apparent CNVs.
PMP22-RAI1 Duplication Can Be Part of a Highly
Complex Chromothripsis/Chromoanasynthesis Event
The CGRs involving the PMP22-RAI1 duplication can be
exceedingly complex. Cytogenetic and molecular analysis,
including FISH, chromosome analysis and low-resolution
BAC array CGH, were used to investigate the genome of
BAB 2337, and a complex rearrangement was revealed.Journal of Human Genetics 97, 691–707, November 5, 2015 697
Table 2. Breakpoint Junction Features of the Rearrangements Identified in 23 Subjects with PMP22-RAI1 Contiguous Gene Duplications
Individual
BAB# CNV pattern Inheritance
Breakpoint junction
Segments Coordinates (Chr17)
Distal
boundary
Proximal
boundary Features Ref
527 DUP-NML-DUP
(CGR)
de novo DUP 10954612–14494703 (Min)
10954218–14495430 (Max)
NA NA – –
DUP 14577325–21557321 (Min)
14576885–21701186 (Max)
NA LCR cluster
(17p-PROX)
1229 DEL-NML-DUP
(CGR)
de novo DEL 15075309 a–15113732a Ua Ua 6 bp (ACCTTC)
microhomology
24
DUP 15117983–21531363 (Min)
15117908–21701186 (Max)
NA LCR cluster
(17p-PROX)
1458 TRP-NML-DUP
(CGR)
de novo TRP 13220227–14630812 (Min)
13216466–14630946 (Max)
NA NA – –
DUP 14634801–22205372 (Min)
14633210–25291809 (Max)
NA CEN
1861 DUP de novo DUP 14541090–22213960 (Min)
14540244–25291809 (Max)
NA CEN – –
2211 DUP-NML-DUP
(CGR)
de novo DUP 12739434–12805414a (Min)
12738917–12805414a (Max)
NA RE
(L2a) a
6 bp (TAATTA)
insertion
This
study
DUP 13454298a–22171191 (Min)
13454298a–22181378 (Max)
RE (AluY) a LCR cluster
(PERI-CEN)
2337 DEL1-NML-DUP1-
NML-DEL2-NML-
DUP2-TRP1-DUP2-
TRP2-DUP2
(CGR)
de novo DEL1 0–565389 (Min)
0–566912 (Max)
NA NA Jct1 (AluSp ->
T-rich repeats):
18 bp insertionc
Jct2 (MER4B-int ->
Unique):
33 bp insertionc
Jct3 (L1MA4 ->
Unique):
257 bp insertionc
Jct4 (L1MC4a ->
Unique):
551 bp insertionc
This
study
DUP1 6001081a–6321783a RE
(L1MC4a) a
RE
(AluSp) a
DEL2 11587499a–13490898a Ua Ua
DUP2 13797160–19655692a (Min)
13796836–19655692a (Max)
NA RE
(L1MA4) a
TRP1 14362549a–14429100a RE
(T-rich
repeats) a
RE
(MER4B-int) a
TRP2 17088740a–17596327 (Min)
17088740a–17596376 (Max)
Ua NA
2362 DUP de novo DUP 14507339–21531363 (Min)
14500613–21701186 (Max)
NA LCR cluster
(17p-PROX)
– –
2488 DUP de novo DUP 14062138–21531363 (Min)
14061964–21701186 (Max)
NA LCR cluster
(17p-PROX)
– –
2661 DUP NA DUP 8033957a–19184708a RE
(L1MA7) a
RE
(MER21B) a
2 bp (AT)
microhomology
24
2703 DUP not maternal DUP 8331250–21531363 (Min)
8330470–21701186 (Max)
NA LCR cluster
(17p-PROX)
– –
2711 DEL-NML-DUP
(CGR)
de novo DEL 10930335a–11013899a Ua RE
(MLT1A0) a
1 bp (C) insertion 24
DUP 11164314–22225859 (Min)
11164034–25291809 (Max)
NA CEN
2790 DUP-NML-
INV/DUP
(CGR)
NA DUP 12434682a–12973003 (Min)
12434682a–12973388 (Max)
RE
(L1MEg) a
NA 4 bp (CTTT)
insertion
15
DUP 12999819a–21531363 (Min)
12999819a–21701186 (Max)
U A LCR cluster
(17p-PROX)
3813 DUP not maternal DUP 15060680a–18212609a RE
(MLT1E2) a
RE
(L1MB5) a
17 bpb insertion This
study
6299 DUP de novo DUP 14736306–22234459 (Min)
14735780–25291809 (Max)
NA CEN – –
(Continued on next page)
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Table 2. Continued
Individual
BAB# CNV pattern Inheritance
Breakpoint junction
Segments Coordinates (Chr17)
Distal
boundary
Proximal
boundary Features Ref
6504 DUP-NML-DUP
(CGR)
de novo DUP 13582799–13805140 (Min)
13582620–13805545 (Max)
NA NA – –
DUP 13825917–26507332 (Min)
13825439–26507855 (Max)
NA NA
6635 DUP NA DUP 13376683–21508916 (Min)
13376614–21701186 (Max)
NA LCR cluster
(17p-PROX)
– –
6636 DUP not maternal DUP 14197653a–19928406a RE
(HAL1b) a
Ua 1 bp (A)
microhomology
This
study
6966 DUP NA DUP 10016908a–20511549a Ua LCR cluster
(SMS-REP) a
4 bp (TCAG)
microhomology
This
study
6967 DEL-NML-DUP
(CGR)
NA DEL 2930963–2954284 (Min)
2930296–2967871 (Max)
NA LCR cluster
(distal 17p)
– –
DUP 3156474–22234459 (Min)
3143016–25291809 (Max)
NA CEN – –
6968 DUP NA DUP 1859192–21531363 (Min)
1858544–21701186 (Max)
NA LCR cluster
(17p-PROX)
– –
7679 DUP de novo DUP 11065839–21531640 (Min)
11064378–21701186 (Max)
NA LCR cluster
(17p-PROX)
– –
7873 DUP de novo DUP 13188763–22234459 (Min)
13187737–25291809 (Max)
NA CEN – –
8300 DUP de novo DUP 10608712a–18506553a Ua LCR cluster
(SMS-REP) a
3 bp (CCT)
microhomology
This
study
Abbreviations are as follows: The CGR patterns of DUP-NML-DUP, DEL-NML-DUP, TRP-NML-DUP and DEL1-NML-DUP1-NML-DEL2-NML-DUP2-TRP1-DUP2-
TRP2-DUP2 are described in Figure 1; DUP-NML-INV/DUP, a CGR pattern of DUP-NML-DUP with the distal side of the distal DUP being connected to the distal
side of the proximal DUP in an inverted orientation (INV/DUP). DUP, duplication; DEL, deletion; TRP, triplication; NML, normal-copy segment; INV/DUP, inverted
duplication; CGR, complex genomic rearrangement; U, Unique sequences; RE, Repetitive elements; CEN, centromere; PERI-CEN, pericentromeric; NA, not avail-
able; Min, boundaries of CNVs defined by the two flanking aberration probes; Max, boundaries of CNVs defined by the two flanking normal probes.
aPrecise position of the boundaries for each CNV by breakpoint sequencing. For the boundaries of CNVs without the breakpoint junction sequenced, we deter-
mined the CNV boundaries using the probes flanking the region showing the copy-number transition.
bGCTGTGATTCTGTAAGC.
cDetailed information is in Figure S3.The rearrangements included a terminal deletion of
17p13.3 (DEL1), a deletion of 17p12 (DEL2), and a duplica-
tion of 17p11.2p12 (DUP2: a PMP22-RAI1 duplication)33
(Figures 3A and 3B). FISH experiments also revealed a
balanced insertional translocation event, including a
segment of 17p13.3 (Miller-Dieker lissencephaly syn-
drome [MDLS, MIM 247200] region) being inserted in an
inverted orientation amidst the middle SMS-REP/LCR17pB
block.33 Additionally, FISH revealed unbalanced trans-
location of a duplicated segment of 21q22.3qter to
17p13.3pter (Figure 3A).33
High-resolution array CGH targeting 17p uncovered
additional structural abnormalities. An excess number of
CNVs were identified on the short arm of chromosome
17. In addition to the CNVs identified by FISH, a
small duplication (~300 kb in size) distal to the PMP22-
RAI1 duplication (DUP1) and two triplications (TRP1
and TRP2, approximately 70 kb and 510 kb in size,
respectively) located within the PMP22-RAI1 duplication
region were revealed (Figures 3B and 3C). The overall
pattern of ‘‘DEL1-NML-DUP1-NML-DEL2-NML-DUP2-The AmericanTRP1-DUP2-TRP2-DUP2’’ was reminiscent of chromo-
thripsis or chromoanasynthesis, a phenomenon consisting
of excessive rearrangements apparently concentrated on
one chromosome or one arm of a chromosome.36-38 Break-
point sequencing revealed four junction sequences (Jct1,
Jct2, Jct3, and Jct4, Figure 3D and Table 2). Jct1 connected
the proximal end of DUP1 and the distal end of TRP1 with
an 18 bp insertion observed at the breakpoint junction
(Figure 3D and Figure S3A). This insertion could not be
found in the adjacent genomic regions (40 kb) surround-
ing each breakpoint, indicating a DNA sequence poten-
tially synthesized from a region beyond the nearby region
of the breakpoints. Jct2 connected the proximal end of
TRP1 and the proximal end of DEL2 (Figure 3D). A 33 bp
insertion was observed at the breakpoint junction
Jct2 and could be split into two fragments, including a
2 bp fragment (CT) and a 31 bp fragment potentially
derived from a nearby region (Chr17: 8607208–8607238)
with a 4 bp microhomology (GACA) at the junction
(Figure S3A). Jct3 connected the proximal end of DUP2
and the distal end of DEL2 in an inverted orientationJournal of Human Genetics 97, 691–707, November 5, 2015 699
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Figure 2. Summary Diagram of the Genomic Rearrangements Identified in 17p
The genomic rearrangements identified in 23 subjects are shown together with common recurrent PTLS duplication.
(A) Ideogram showing the entire short arm of chromosome 17.
(B) Detailed information of the genomic rearrangements in 23 subjects. Different types of CNV identified by array CGH were presented
in colored segments. Segments in green, heterozygous deletion; red, duplication; blue, triplication; white, normal copy number;
maroon, LCRs or repetitive sequences (e.g., satellite DNA sequences) at the breakpoint junctions. The plots are arranged according to
the starting coordinate of the rearrangements identified in each case. Colored vertical lines represent genomic location of critical genes
or LCR clusters. Vertical lines in light blue, CMT1A-REPs; magenta, SMS-REPs; maroon, 17p-PROX; black, genes PMP22 and RAI1.
Centromeric region is also noted.
(C) Count of incidences of each genomic rearrangement. CR, common recurrent PTLS duplication. The incidence is one for the rear-
rangements labeled with BAB numbers.(Figure 3D). A 257 bp insertion was observed at Jct3 and
could be divided into four fragments, including a 4 bp
fragment (ACTT), a 128 bp fragment (ins1, derived
from Chr17: 17575856–17575983), an 85 bp fragment
(ins2, derived from Chr17: 17576136–17576220) and a
32 bp fragment (ins3, derived from Chr17: 17568995–
17569026) (Figure S3A). Microhomologies (TGC, CA and
GCA, respectively) were observed at each transition point
(Figure S3A). Jct4, connecting the distal end of DUP1
and the distal end of TRP2 in an inverted orientation,
was observed with a 551 bp insertion that might be
partially derived from sequences in chromosomes 21
(Chr21: 43658009–43658301) and 17 (Chr17: 17597062–
17597133) (Figure 3D and Figure S3A). At least two tem-
plate switches are required to generate one intact inserted
sequence; thus at least (Nþ1) template switches are poten-
tially required to generate N number of intact insertions700 The American Journal of Human Genetics 97, 691–707, Novemb(Figures S3B and S3C). DNA repair and replication after
double-strand break is error-prone and might undergo iter-
ative template switches due to the usage of a low-processiv-
ity DNA polymerase.26,34,39 Multiple insertion fragments
were revealed by the breakpoint junction sequences of
BAB 2337, indicating iterative template switches before
the establishment of a processive replicative fork. In addi-
tion,microhomologieswereobserved to catenateDNAfrag-
ments from different origin. The cumulative evidence sug-
gests FoSTeS/MMBIR as the likely mechanism for forming
the CGR in BAB 2337. The breakpoint junction sequence
connecting the proximal end of TRP2 and the distal end
of DUP2 was not determined. It indicated that potential
cryptic complexity undetectable by array CGH might un-
derlie the rearrangement. A balanced insertional transloca-
tion event of a segment from the 17p13.3 MDLS region
being invertedly inserted in the middle SMS-REP/LCR17pBer 5, 2015
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Figure 3. Complex Genomic Rearrangement in BAB 2337
(A) An overview of genomic rearrangements identified in the entire genome of BAB 2337. Top panel shows duplicated segment in
21q22.3, which is translocated to 17pter shown by FISH.33 Bottom panel shows rearrangements occur in chromosome 17. The unbal-
anced translocation between 17p and 21q is shown by the red oval and arrow.
(B) Zoom-in view of genomic rearrangements in 17p. It excludes the terminal deletion in 17p13.3.
(C) Diagram showing the dosage changes based on array CGH analysis. Colored segments represent the dosage changes. Number of seg-
ments stacking at the same position indicates absolute copy number. Segments in red, copy-number gain; green; copy-number loss; gray,
normal copy number. Abbreviations are as follows: DEL, deletion; DUP, duplication; TRP, triplication. ‘‘X,’’ copy number.
(D) Schematic diagram showing the potential rearrangement-generating mechanism. Colored arrows indicate the replication direction.
Dashed lines between arrows represent breakpoint junctions (Jct). Arrows in black, red, blue, and yellow indicate replications on the (þ)
strand in a same direction. The arrows in green indicate a replication on the () strand. The arrow and dashed line in gray represents a
potential process to generate the unmapped, putative Jct5. The potential final product of rearrangement is shown at the bottom.block has been reported previously33—this rearrangement
is apparently copy-number neutral and thus cannot be de-
tected by array CGH technique. Such type of complexity
might evade detection and breakpoint junction determina-
tion by currently used methodologies.40Discussion
PTLS has an estimated incidence of 1:50,000, while CMT
(includes all of its molecular genetic forms, of whichThe AmericanCMT1A is the most commonly observed) has a total prev-
alence rate of 1:2,500. Thus the expected prevalence of
cases with concurrence of PTLS and CMT1A can be esti-
mated at 1:125,000,000 based on the hypothesis that
PTLS and CMT1A are independent events. However,
because the two loci are in relatively close physical prox-
imity (mapping ~2.5 Mb apart, Figure 4B), they can theo-
retically be involved in a single mutational event with
both dosage sensitive genes mapping within a duplicated
genomic segment. In our study, 23 subjects have been
identified with PMP22-RAI duplication within a cohort ofJournal of Human Genetics 97, 691–707, November 5, 2015 701
BPMP22
Distal Proximal
LCR17pA LCR17pE
Distal ProximalMiddle
LCR17pF
LCR17pB LCR17pC LCR17pD
LCR17pG
CMT1A-REPs SMS-REPs
RAI1
TEL
(Distal)
RNU3
LCRs
CMT1A dup PTLS dup (CR, 84/127)
PTLS dup (UR1, 5/127)
LCRs
PMP22 RAI1
Gaps
A chr17: 1-22,200,000
~ 2.5 Mb
CEN
(Proximal)
17p-PROX
0 5 10 15 20
0
2
4
6
8
10
 
D
en
si
ty
14 16 18 20 22
0
2
4
6
8
10
Coordinates (Mb)
D
en
si
ty
CMT1A-REP
(distal)
CMT1A-REP
(proximal)
SMS-REP
(distal)
SMS-REP
(middle)
SMS-REP
(proximal)
C
PMP22 RAI1
0
1
17p11.217p11.217p13.117p13.217p13.3
Figure 4. Genomic Architecture in the
Chromosome 17p Region
(A) Distribution of LCRs in chromosome
17p shown by the Segmental Dups track
in the UCSC genome browser (hg19).
Colored segments represent LCRs. Black
triangles represent PMP22 and RAI1. Re-
gions with gaps are shown as black seg-
ments on top of the LCR track. The gray
box indicates proximal 17p region.
(B) LCR-rich genomic structure in the
proximal 17p region. LCR clusters are
shown by colored segments. Segments in
blue, CMT1A-REPs; magenta, SMS-REPs;
gray, LCR17pA-G; black hatched, RNU3
LCRs responsible for idic(17q); maroon
hatched, 17p-PROX. The common recur-
rent CMT1A duplication, common recur-
rent (CR) and uncommon recurrent
(UR1) PTLS duplications are shown as
black segments between vertical dashed
lines. Distance between PMP22 and RAI1
is approximately 2.5 Mb.
(C) LCR density plot in chromosome 17p
region. The plot is based on the annotation
in the Segmental Dups track from the
UCSC Genome Browser. Top panel shows
the ideogram of chromosome 17p. Middle
panel is the LCR density plot showing the
moving-average of LCR density along the
chromosome 17p region. LCR density
might be higher than 1 if multiple overlap-
ping LCRs cluster in a given window.
Density of other repetitive sequences
from RepeatMasker is shown at the top in red. The bottom panel is zoom-in view of the middle panel focusing on the proximal 17p
region. Major LCR clusters and genes are annotated. Region between vertical maroon lines indicate the 17p-PROX, and the region
with gray shade represents the gap region in hg19, which is recently filled by satellite DNA sequences in hg38.127 subjects (23/127, 18.11%) with duplications encom-
passing RAI1. Specifically, PMP22-RAI1 duplications ac-
count for 23/43 (53%) of subjects with uncommon or
noncurrent rearrangements, which emphasizes the impor-
tance of pursuing a molecular diagnosis in subjects with
PTLS (Figure S4). Moreover, prognostic information pro-
vided for PTLS subjects with PMP22-RAI1 duplications is
different from that for typical PTLS resulting from com-
mon recurrent duplication. Furthermore, neuropathy can
be monitored for in the relevant cases guided by molecular
diagnosis.
Infantile hypotonia, failure to thrive, and develop-
mental delay are common features of PTLS,7,28,41 whereas
the clinical manifestations of CMT1A do not present dur-
ing infancy, yet develop gradually during the first 2
decades. Delayed walking is seen in the vast majority of
persons with PTLS, while individuals with CMT1A typi-
cally attain early developmental milestones without diffi-
culty.42 In the current cohort, delayed walking (beyond
age 15months) was observed in 13 of 14 subjects; and clin-
ical neuropathy developed in the first decade in 9 of 10
subjects for which this information is available (Table 1).
Although it is possible that the molecular diagnosis pro-
vided an ascertainment bias and clinicians were more
likely to diagnose the peripheral neuropathy at an early
age, it is plausible to suggest that both the motor delay702 The American Journal of Human Genetics 97, 691–707, Novemband the neuropathy were exacerbated by the combination
of central and peripheral nervous system abnormalities in
subjects with PMP22-RAI1 duplications.
Talipes equinovarus has been reported in association
with PTLS, and was suggested to be a result of perturbed
regulation of PMP22 in a subject with the common recur-
rent PTLS duplication.10,15 A case (261273) with a
PMP22-RAI1 duplication has been reported in DECIPHER
with indications including intellectual disability, micro-
gnathia, muscular hypotonia, prominent nasal bridge,
and talipes equinovarus. Interestingly, 2 of 15 subjects in
our cohort had congenital talipes equinovarus, possibly
related to their peripheral neuropathy. Syringomyelia, a
fluid-filled cyst within the spinal cord, was found in two
of the four subjects who had a spinal MRI (Table 1, Table
S1). This malformation is not typically associated with
CMT1A or PTLS and might suggest that a spine MRI be
considered in subjects with the PMP22-RAI1 duplication.
While structural renal abnormalities have been reported
in 19%–35% of subjects with Smith-Magenis syn-
drome,43,44 they are considered relatively infrequent
(<10%) in subjects with PTLS.16 Goh et al. highlighted
FLCN (MIM 607273) as a possible candidate gene con-
tributing to renal abnormalities in subjects with PTLS-asso-
ciated duplications.45 The association between gain-of-
function mutations (e.g., duplications) of FLCN and renaler 5, 2015
abnormalities warrants further investigation. The slightly
higher incidence (3/11 or 27%) of structural renal abnor-
malities in our cohort might suggest the consideration of
an additional dosage sensitive gene involved in kidney
development, possibly located in between the map posi-
tions of the recurrent CMT1A and PTLS duplications.
Boundaries of the PMP22-RAI1 duplication are not
confined by the LCR-rich architecture on 17p. LCR-rich
architecture in the 17p11.2p12 region determines recur-
rent, disease-causing CNVs. The genomic architecture of
major LCR clusters, including CMT1A-REPs, SMS-REPs,
RNU3 LCRs, and LCR17pA/B/C/D/E/F/G clustering with
the SMS-REPs, has been delineated in several studies using
BAC clone sequencing, FISH, Southern blot, and pulsed-
field gel electrophoresis (Figure 4B).11,21,46-48 These LCR
clusters are involved in the formation of uncommon recur-
rent 17p11.2 deletion/duplication CNV (UR1 and UR2),
translocations and marker chromosomes identified in sub-
jects with SMS/PTLS phenotypes, as well as somatic
isochromosome 17q leading to malignancies.16,46,49-53
Although LCR clusters surround both the PMP22 and
RAI1 loci, the CMT1A-REPs (flank PMP22 and mediate
CMT1A duplication) and SMS-REPs (flank RAI1 and
mediate PTLS duplication) do not share extensive homol-
ogy. In fact, no extensive directly-oriented homology distal
to PMP22 has been observed to partner the LCRs proximal
to RAI1; thus a pairing LCR defined genomic interval en-
compassing both PMP22 and RAI1 is lacking (Figure 4C).
As a result and consistent with our experimental observa-
tions, a recurrent rearrangement for PMP22-RAI1 duplica-
tion is unlikely.
Other than NAHRmediated by homologous LCRs, struc-
tural rearrangements might be generated by replicative
mechanisms, which result from DNA replication error
and repair. FoSTeS/MMBIR has been proposed to generate
rearrangements with microhomologies at the breakpoint
junction.25,26 Single-end, double-strand breaks can result
from mitotic replication fork collapse, which allows the
single-strand 30 end to undergo template switches to a
nearby replication fork primed by Watson-Crick base pair-
ing via microhomologies to continue replication.23,24,34
The position of re-establishment of a processive replication
fork determines the pattern (duplication, deletion, inver-
sion, translocation, etc.) and size of rearrangements. The
process of template switching with subsequent replication
can be homology-independent, or mediated by limited ho-
mology, termed microhomology; chromosomal structural
changes resulting from such replicative processes are
attributed to the FoSTeS/MMBIR model.26,34,40 The obser-
vation of microhomology at the breakpoint junction of
several rearrangements encompassing PMP22-RAI1 dupli-
cations is consistent with the FoSTeS/MMBIR model (Table
2). The small-scale complexities in the form of templated
insertions from an adjacent region in close proximity in-
serted at the breakpoint junctions are also observed in a
number of cases, which are characteristic of the low-proc-
essivity, low-fidelity replication process in MMBIR.38,39The AmericanFoSTeS/MMBIR requires microhomology or no homology,
thus it is independent of the long homology provided by
LCRs concentrated in the chromosome 17p11.2p12
region.
The distribution of copy-number variants is not random
based on experimental observation.26 This might be
affected by multiple factors, such as DNA sequence fea-
tures. CNVs are more frequently observed at the centro-
meric or pericentromeric regions, which are also enriched
with LCR content.54,55 LCRs have been proposed to cata-
lyze genomic rearrangement; nonrecurrent and complex
structural changes tend to occur close to LCRs, and a
breakage/recombination-stimulating role has been pro-
posed for LCRs.38,46 Secondary structure may form within
LCRs, and thereby cause replication fork stalling followed
by template switches during DNA replication.40 Chromo-
somal region 17p11.2p12 is enriched with LCRs, which
are also termed segmental duplications based on computa-
tional characterization.56 According to our analysis, LCRs
constitute approximately 36.52% of genomic sequences
of 17p11.2, 23.06% of 17p11.2p12 and 12.86% of the
entire short arm of chromosome 17. These regions thus
have approximately seven-, four-, and two-fold greater
segmental duplications respectively as compared to the
genome average of 5.13%.
In a total number of 36 putative breakpoint junctions
characterized by array CGH on 17p, we observe involve-
ment of LCRs at 13 junctions (termed LCR-associated
junctions), 12 of which are located in the 17p11.2 region
(Table 2), constituting 12/36 (33.33%) of total breakpoint
junctions. The fraction of LCR-associated events observed
in the 17p11.2 region is similar to the LCR concentration
(36.52%) in the same region, thus the enrichment of
LCRs at breakpoint junctions cannot be implicated. It
might be explained by: (1) small sample size, and (2) using
a selected cohort with a specific phenotype.
Interestingly, nine LCR-associated junctions in nine
samples (Figure 2, Table 2) are located at an LCR cluster
in the proximal 17p region (termed 17p-PROX), consti-
tuting 75% (9/12) of the entire observed LCR-associated
junctions. Among the entire LCR sequences in 17p11.2,
17p-PROX is ~160 kb (7.07%) in contrast to ~2,104 kb
(92.93%) remaining LCR sequences in 17p11.2. The
observation of 9 out of 12 LCR-associated junctions dem-
onstrates an enrichment of junctions in the 17p-PROX
(chi-square test, p < 0.0001). Remarkably, the enrichment
of breakpoint in LCR has also been demonstrated at other
loci, such as MECP2 locus, by high-resolution array CGH
and breakpoint junction sequencing.57
There exists a gap in the middle of 17p-PROX in hg19
surrounded by highly enriched LCR sequences (Figure 4C).
This gap was recently resolved with additional LCR se-
quences in hg38 (GRCh38/hg38) together with, interest-
ingly, an ~141 kb stretch of microsatellite DNA sequences
(AT content 61.36%). Satellite DNA sequences are hyper-
mutable and present in pericentromeric regions or centro-
meres and are involved in the formation of RobertsonianJournal of Human Genetics 97, 691–707, November 5, 2015 703
translocations, pericentric inversions, and translocations
involving 17p11.46,58-61 Furthermore, it is noteworthy
that there are six rearrangements identified in this study
to have at least one breakpoint that resides in the centro-
meric 17p11q11 region (Figure 2, Table 2); karyotyping
and FISH analysis for two of these six subjects, BABs
1458 and 1861, have demonstrated that the duplicated
segment mapped on chromosome 17 in both cases and
created an isodicentric 17 in BAB 1861.29,32 These findings
suggest that satellite DNA sequences might affect genomic
instability and result in rearrangements. Mechanisms
including homologous recombination and DNA breakage
followed by erroneous DNA repair have been proposed
for satellite DNA sequence-mediated translocations.59 For
instance, satellite III, composed of short monomers
(~5 bp), might be involved in forming nonrecurrent trans-
locations.59 Thus, the long stretch of satellite DNA
sequences residing in the 17p-PROX and 17p11 region
might be the responsible genome architectural feature for
the nonrecurrent duplications observed in our study.
These might also act in concert with the LCR-rich genomic
architecture in the pericentromeric region to incite
genomic instability and facilitate genomic rearrangement
formation (Figure 4C). However, due to the highly
complex and repetitive nature of the satellite DNA se-
quences, they are recalcitrant to precise breakpoint map-
ping and sequencing. Thus, single-molecule long-read
sequencing—perhaps single-molecule real-time (SMRT)
sequencing62—might be required to resolve breakpoint
junctions of the rearrangements that occur at pericentro-
meric or centromeric regions.63,64 The single-molecule
long-read sequencing technologies might also be benefi-
cial to the sequencing of breakpoint junctions of rear-
rangements involving other repeats (e.g., LCRs) or
repetitive sequences (e.g., Alus) in this study.
In conclusion, we characterized the genomic rearrange-
ments in subjects with PMP22-RAI1 duplications by high-
resolution array CGH. Subjects with such duplication
might have a blended CMT1A and PTLS phenotypes. The
motor delay and neuropathy might be exaggerated by
the combined abnormalities of the central (PTLS) and pe-
ripheral (CMT1A) nervous system with a potential earlier
onset. Additional clinical presentations, including struc-
tural renal abnormalities, might be observed in subjects
with PMP22-RAI1 duplications due to the extra duplicated
genomic material with a potential gene contributing to
renal development. Breakpoint junction sequencing re-
vealed likely replicative mechanisms, perhaps FoSTeS/
MMBIR, contribute to the rearrangements involving
PMP22-RAI1 duplications. Suchmechanismmight be inde-
pendent of pairing LCR substrate architecture, and result
in larger CNVs leading to a contiguous gene syndrome
with multiple disease loci affected; i.e., the PMP22-RAI1
contiguous gene duplication syndrome. Breakpoint junc-
tions with potential repetitive sequence origin were signif-
icantly enriched in the cohort studied. It indicates that, at
least in chromosome 17p, repetitive sequences, especially704 The American Journal of Human Genetics 97, 691–707, Novembsatellite DNA sequences, might predispose to genomic re-
arrangement resulting in the PMP22-RAI1 duplication.Supplemental Data
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